SINOMAB BIOSCIENCE LIMITED (03681) Releases November 2025 Monthly Return

Bulletin Express12-04

According to the latest return for equity issuers submitted to Hong Kong Exchanges and Clearing Limited, the total issued ordinary share capital of SINOMAB BIOSCIENCE LIMITED remained at 1,386,638,336 shares as of 30 November 2025. No shares were issued or cancelled during the reporting month, and there were no movements in treasury shares.

The 2022 Share Option Scheme, approved on 26 October 2022 and amended on 14 June 2024, recorded 69,009,462 outstanding options at the beginning and end of November 2025. No additional shares were issued or transferred from treasury under this scheme, and no funds were raised from any exercise of options.

All other categories of securities, including warrants, convertibles, and other arrangements to issue shares, reported no activity during the period. The company confirmed compliance with relevant listing rules and legal requirements in issuing and handling its securities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1103946713?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-04 16:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1103946713","market":"us","top_or_hot":-1,"title":"SINOMAB BIOSCIENCE LIMITED (03681) Releases November 2025 Monthly Return","media":"Bulletin Express","content":"<p>According to the latest return for equity issuers submitted to Hong Kong Exchanges and Clearing Limited, the total issued ordinary share capital of SINOMAB BIOSCIENCE LIMITED remained at 1,386,638,336 shares as of 30 November 2025. No shares were issued or cancelled during the reporting month, and there were no movements in treasury shares.</p>\n<p>The 2022 Share Option Scheme, approved on 26 October 2022 and amended on 14 June 2024, recorded 69,009,462 outstanding options at the beginning and end of November 2025. No additional shares were issued or transferred from treasury under this scheme, and no funds were raised from any exercise of options.</p>\n<p>All other categories of securities, including warrants, convertibles, and other arrangements to issue shares, reported no activity during the period. The company confirmed compliance with relevant listing rules and legal requirements in issuing and handling its securities.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SINOMAB BIOSCIENCE LIMITED (03681) Releases November 2025 Monthly Return</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSINOMAB BIOSCIENCE LIMITED (03681) Releases November 2025 Monthly Return\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-04 16:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>According to the latest return for equity issuers submitted to Hong Kong Exchanges and Clearing Limited, the total issued ordinary share capital of SINOMAB BIOSCIENCE LIMITED remained at 1,386,638,336 shares as of 30 November 2025. No shares were issued or cancelled during the reporting month, and there were no movements in treasury shares.</p>\n<p>The 2022 Share Option Scheme, approved on 26 October 2022 and amended on 14 June 2024, recorded 69,009,462 outstanding options at the beginning and end of November 2025. No additional shares were issued or transferred from treasury under this scheme, and no funds were raised from any exercise of options.</p>\n<p>All other categories of securities, including warrants, convertibles, and other arrangements to issue shares, reported no activity during the period. The company confirmed compliance with relevant listing rules and legal requirements in issuing and handling its securities.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03681","symbol_name":"中国抗体-B","start_time":0,"source_url":"","article_id":"1103946713","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1103946713","pubTimestamp":1764838374,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"According to the latest return for equity issuers submitted to Hong Kong Exchanges and Clearing Limited, the total issued ordinary share capital of SINOMAB BIOSCIENCE LIMITED remained at...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03681":"中国抗体-B"},"translate_title":"中国抗体生物科技有限公司(03681)发布2025年11月月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03681":1},"content_text":"According to the latest return for equity issuers submitted to Hong Kong Exchanges and Clearing Limited, the total issued ordinary share capital of SINOMAB BIOSCIENCE LIMITED remained at 1,386,638,336 shares as of 30 November 2025. No shares were issued or cancelled during the reporting month, and there were no movements in treasury shares.\nThe 2022 Share Option Scheme, approved on 26 October 2022 and amended on 14 June 2024, recorded 69,009,462 outstanding options at the beginning and end of November 2025. No additional shares were issued or transferred from treasury under this scheme, and no funds were raised from any exercise of options.\nAll other categories of securities, including warrants, convertibles, and other arrangements to issue shares, reported no activity during the period. The company confirmed compliance with relevant listing rules and legal requirements in issuing and handling its securities.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1103946713","isCrawlerRequest":true}